reports
Swedish Orphan Biovitrum AB: 1 director
A director at Swedish Orphan Biovitrum AB maiden bought 1,900 shares at 405.333SEK and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the l...
- ABGSC Healthcare Research
- Georg Tigalonov-Bjerke
- Morten Larsen
- ABGSC Healthcare Research
- Julia Sundvall
- Philip Ekengren
- ABGSC Healthcare Research
- Julia Sundvall
- Philip Ekengren
- ABGSC Healthcare Research
- Georg Tigalonov-Bjerke
- Morten Larsen
FRO – Time Charter-Out Contracts for Seven VLCCs
FRO – Time Charter-Out Contracts for Seven VLCCs Frontline plc (“Frontline” or the “Company”) (NYSE and OSE: FRO) is pleased to announce that it has entered into one-year time charter-out agreements for seven of its VLCCs. The charters will commence during the period from late-January to April 2026 at a rate of $76,900 per day per vessel. Lars H. Barstad, Chief Executive Officer of Frontline Management AS, commented: “We are in unprecedented times, and these are charter-out-levels not seen for decades. Frontline remains largely spot exposed after these contracts become effective, retaining...
- ABGSC Healthcare Research
- Georg Tigalonov-Bjerke
- Morten Larsen
- ABGSC Healthcare Research
- Julia Sundvall
- Philip Ekengren
FRO – Strategic Fleet Renewal and Expansion
FRO – Strategic Fleet Renewal and Expansion Acquisition and Sale of VLCCs Frontline plc (“Frontline”) (NYSE: FRO – OSE: FRO) announces a strategic fleet renewal initiative, involving both the acquisition of new vessels and the sale of older vessels. Sale of eight of its oldest 1st generation ECO VLCCs The Company has entered into an agreement to sell eight of its oldest 1st generation ECO Very Large Crude Carriers (VLCCs), built between 2015 and 2016. These vessels are being sold for a total sales price of $831.5 million, with delivery to the new owner scheduled during the first quarter...
- ABGSC Healthcare Research
- Georg Tigalonov-Bjerke
- Morten Larsen
FRO – 2025 Annual General Meeting
FRO – 2025 Annual General Meeting Frontline plc (the “Company”) advises that the 2025 Annual General Meeting of the Shareholders of the Company was held on 8 December 2025 at 09:00 a.m. at Metis Tower, 28th October Avenue and Iakovou Tombazi Street, 4th floor, 3107 Limassol, Cyprus. The audited consolidated financial statements for the Company for the year ended 31 December 2024 were presented to the Meeting. In addition, the following resolutions were passed: To re-elect John Fredriksen as a Director of the Company. To re-elect James O’Shaughnessy as a Director of the Company.To re-elec...
FRO - Q3 2025 Presentation
FRO - Q3 2025 Presentation Please find enclosed the presentation of Frontline plc's third quarter 2025 results to be held on the webcast / conference call 21 November, 2025 at 15:00 CET. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachment
FRO – Third Quarter and Nine Months 2025 Results
FRO – Third Quarter and Nine Months 2025 Results FRONTLINE PLC REPORTS RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025 Frontline plc (the “Company”, “Frontline,” “we,” “us,” or “our”), today reported unaudited results for the three and nine months ended September 30, 2025: Highlights Profit of $40.3 million, or $0.18 per share for the third quarter of 2025.Adjusted profit of $42.5 million, or $0.19 per share for the third quarter of 2025.Declared a cash dividend of $0.19 per share for the third quarter of 2025.Reported revenues of $432.7 million for the third quarter of 2025.Achie...
FRO – Notice of Annual General Meeting 2025
FRO – Notice of Annual General Meeting 2025 Frontline plc (the “Company”) announces that its 2025 Annual General Meeting will be held on December 8, 2025. A copy of the Notice of Annual General Meeting and associated information including the Company’s Annual Report on Form 20-F for 2024 can be found on our website at and attached to this press release. November 14, 2025Limassol, Cyprus This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Attachments ...
FRO – Invitation to Q3 2025 Results Conference Call and Webcast
FRO – Invitation to Q3 2025 Results Conference Call and Webcast Frontline plc.’s preliminary third quarter 2025 results will be released on Friday November 21, 2025, and a webcast and conference call will be held at 3:00 p.m. CET (9:00 a.m. U.S. Eastern Time). The results presentation will be available for download from the Investor Relations section at ahead of the conference call. In order to attend the conference call you may do one of the following: a. WebcastGo to the Investor Relations section at and follow the “Webcast” link, or access directly from the link below. b. Conferen...
- ABGSC Healthcare Research
- Julia Sundvall
- Philip Ekengren
Data presented at ACR Convergence 2025 highlight Sobi’s commitment to ...
Data presented at ACR Convergence 2025 highlight Sobi’s commitment to advancing care across rare and underserved inflammatory conditions NASP data highlight reduction in disease burden among people living with uncontrolled gout Gamifant (emapalumab) data showed response rates in patients with MAS in Still’s disease across MAS subtypes, including in those with recurrent disease Discussion of the first ever international, randomized, multicentre, double-blind, placebo-controlled phase 2 dose finding trial of Vonjo® (pacritinib) in adult patients with VEXAS syndrome WALTHAM, Mass., Oct. 25...
- ABGSC Healthcare Research
- Julia Sundvall
- Philip Ekengren
- ABGSC Healthcare Research
- Georg Tigalonov-Bjerke
- Morten Larsen
- ABGSC Healthcare Research
- Georg Tigalonov-Bjerke
- Morten Larsen
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.